Nuvation Bio Inc Class A — Quarterly Financial Statistics (NYSE:NUVB) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Cash from operating activities -31.09 M-46.3 M-42.63 M-48.18 M-52.89 M -190 M Cash from investing activities 29.12 M51.77 M54.18 M54.88 M-96.62 M 64.21 M Cash from financing activities -1.54 M-900 K548 K193.42 M501 K 193.57 M Free cash flow -31.23 M-46.29 M-42.7 M-48.36 M-52.9 M -190.25 M

Haberler

Regenxbio (RGNX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Tracking David Abrams' Abrams Capital Management Portfolio - Q4 2025 Update

Nuvation Bio, IDH1 mutasyonlu gliom için SIGMA denemesini faz 3’e genişletiyor

Nuvation Bio expands SIGMA trial to phase 3 for IDH1-mutant glioma

Nuvation Bio hissesi, Ibtrozi satış ivmesi sayesinde B.Riley’den Al notunu korudu

Nuvation Bio stock maintains Buy rating at B.Riley on Ibtrozi sales momentum

Nuvation Bio: Rollout Data Of Ibtrozi Support A Modest Buy (NYSE:NUVB)

Truist Securities, Ibtrozi’nin benimsenmesi üzerine Nuvation Bio hisse fiyat hedefini 13 dolara yükseltti

Truist Securities raises Nuvation Bio stock price target to $13 on Ibtrozi uptake

Jones Trading raises Nuvation Bio stock price target to $12 on safusidenib study

Down 24% in 4 Weeks, Here's Why Nuvation Bio (NUVB) Looks Ripe for a Turnaround

H.C. Wainwright, Nuvation Bio için hisse fiyat hedefini 17 dolara düşürdü